JB
AGIO icon

Julian Baker’s Agios Pharmaceuticals AGIO Stock Holding History

Julian Baker’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-189,866
Closed -$7.62M – 88
2025
Q3 		$7.62M Hold
189,866
– – 0.06% 66
2025
Q2 		$6.31M Buy
+189,866
New +$5.75M 0.06% 61
2018
Q1 		– Sell
-128,666
Closed -$7.36M – 115
2017
Q4 		$7.36M Hold
128,666
– – 0.06% 66
2017
Q3 		$8.59M Hold
128,666
– – 0.07% 56
2017
Q2 		$6.62M Hold
128,666
– – 0.06% 58
2017
Q1 		$7.51M Hold
128,666
– – 0.06% 56
2016
Q4 		$5.37M Sell
128,666
-79,249
-38% -$4.16M 0.05% 60
2016
Q3 		$11M Hold
207,915
– – 0.1% 52
2016
Q2 		$8.71M Sell
207,915
-100,000
-32% -$4.94M 0.09% 59
2016
Q1 		$12.5M Buy
307,915
+207,915
+208% +$8.89M 0.13% 49
2015
Q4 		$6.49M Hold
100,000
– – 0.05% 70
2015
Q3 		$7.06M Hold
100,000
– – 0.07% 69
2015
Q2 		$11.1M Sell
100,000
-49,954
-33% -$5.38M 0.1% 61
2015
Q1 		$14.1M Sell
149,954
-13,439
-8% -$1.51M 0.12% 52
2014
Q4 		$18.3M Sell
163,393
-6,500
-4% -$580K 0.19% 39
2014
Q3 		$10.4M Sell
169,893
-30,000
-15% -$1.29M 0.13% 42
2014
Q2 		$9.16M Hold
199,893
– – 0.11% 47
2014
Q1 		$7.83M Sell
199,893
-5,857
-3% -$196K 0.1% 55
2013
Q4 		$4.93M Buy
205,750
+5,750
+3% +$131K 0.07% 65
2013
Q3 		$5.59M Buy
+200,000
New +$5.52M 0.08% 54

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Julian Baker's AGIO Position: Q4 2025 in Review

Julian Baker sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 189,866 shares — an estimated $7.62M sold.

Julian Baker first reported a position in AGIO in Q3 2013 and held it in 20 quarters. The position peaked at $18.3M in Q4 2014. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Julian Baker reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Julian Baker sold 189,866 Agios Pharmaceuticals shares in Q4 2025, an estimated $7.62M.
  • Julian Baker first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 20 quarters.
  • Julian Baker's Agios Pharmaceuticals position peaked at $18.3M in Q4 2014.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Baker Bros. Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.